189 related articles for article (PubMed ID: 33778323)
1. Abnormal Bone Collagen Cross-Linking in Osteogenesis Imperfecta/Bruck Syndrome Caused by Compound Heterozygous
Gistelinck C; Weis M; Rai J; Schwarze U; Niyazov D; Song KM; Byers PH; Eyre DR
JBMR Plus; 2021 Mar; 5(3):e10454. PubMed ID: 33778323
[TBL] [Abstract][Full Text] [Related]
2. Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.
Gistelinck C; Witten PE; Huysseune A; Symoens S; Malfait F; Larionova D; Simoens P; Dierick M; Van Hoorebeke L; De Paepe A; Kwon RY; Weis M; Eyre DR; Willaert A; Coucke PJ
J Bone Miner Res; 2016 Nov; 31(11):1930-1942. PubMed ID: 27541483
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2.
Ha-Vinh R; Alanay Y; Bank RA; Campos-Xavier AB; Zankl A; Superti-Furga A; Bonafé L
Am J Med Genet A; 2004 Dec; 131(2):115-20. PubMed ID: 15523624
[TBL] [Abstract][Full Text] [Related]
4. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.
Mumm S; Gottesman GS; Wenkert D; Campeau PM; Nenninger A; Huskey M; Bijanki VN; Veis DJ; Barnes AM; Marini JC; Stolina M; Zhang F; McAlister WH; Whyte MP
Bone; 2020 Jan; 130():115047. PubMed ID: 31472299
[TBL] [Abstract][Full Text] [Related]
5. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
Schwarze U; Cundy T; Pyott SM; Christiansen HE; Hegde MR; Bank RA; Pals G; Ankala A; Conneely K; Seaver L; Yandow SM; Raney E; Babovic-Vuksanovic D; Stoler J; Ben-Neriah Z; Segel R; Lieberman S; Siderius L; Al-Aqeel A; Hannibal M; Hudgins L; McPherson E; Clemens M; Sussman MD; Steiner RD; Mahan J; Smith R; Anyane-Yeboa K; Wynn J; Chong K; Uster T; Aftimos S; Sutton VR; Davis EC; Kim LS; Weis MA; Eyre D; Byers PH
Hum Mol Genet; 2013 Jan; 22(1):1-17. PubMed ID: 22949511
[TBL] [Abstract][Full Text] [Related]
6. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
[TBL] [Abstract][Full Text] [Related]
7. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
[TBL] [Abstract][Full Text] [Related]
8. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome.
Lv F; Xu X; Song Y; Li L; Asan ; Wang J; Yang H; Wang O; Jiang Y; Xia W; Xing X; Li M
Calcif Tissue Int; 2018 Mar; 102(3):296-309. PubMed ID: 29177700
[TBL] [Abstract][Full Text] [Related]
9. Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2.
Leal GF; Nishimura G; Voss U; Bertola DR; Åström E; Svensson J; Yamamoto GL; Hammarsjö A; Horemuzova E; Papadiogannakis N; Iwarsson E; Grigelioniene G; Tham E
J Bone Miner Res; 2018 Apr; 33(4):753-760. PubMed ID: 29178448
[TBL] [Abstract][Full Text] [Related]
10. Decrease of lysyl hydroxylase 2 activity causes abnormal collagen molecular phenotypes, defective mineralization and compromised mechanical properties of bone.
Saito T; Terajima M; Taga Y; Hayashi F; Oshima S; Kasamatsu A; Okubo Y; Ito C; Toshimori K; Sunohara M; Tanzawa H; Uzawa K; Yamauchi M
Bone; 2022 Jan; 154():116242. PubMed ID: 34718219
[TBL] [Abstract][Full Text] [Related]
11. Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.
Barnes AM; Duncan G; Weis M; Paton W; Cabral WA; Mertz EL; Makareeva E; Gambello MJ; Lacbawan FL; Leikin S; Fertala A; Eyre DR; Bale SJ; Marini JC
Hum Mutat; 2013 Sep; 34(9):1279-88. PubMed ID: 23712425
[TBL] [Abstract][Full Text] [Related]
12. Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome--osteogenesis imperfecta phenotypic spectrum.
Puig-Hervás MT; Temtamy S; Aglan M; Valencia M; Martínez-Glez V; Ballesta-Martínez MJ; López-González V; Ashour AM; Amr K; Pulido V; Guillén-Navarro E; Lapunzina P; Caparrós-Martín JA; Ruiz-Perez VL
Hum Mutat; 2012 Oct; 33(10):1444-9. PubMed ID: 22689593
[TBL] [Abstract][Full Text] [Related]
13. Bruck syndrome in 13 new patients: Identification of five novel FKBP10 and PLOD2 variants and further expansion of the phenotypic spectrum.
Otaify GA; Abdel-Hamid MS; Hassib NF; Elhossini RM; Abdel-Ghafar SF; Aglan MS
Am J Med Genet A; 2022 Jun; 188(6):1815-1825. PubMed ID: 35278031
[TBL] [Abstract][Full Text] [Related]
14. Disentangling mechanisms involved in collagen pyridinoline cross-linking: The immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2.
Gjaltema RA; van der Stoel MM; Boersema M; Bank RA
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7142-7. PubMed ID: 27298363
[TBL] [Abstract][Full Text] [Related]
15. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis.
van der Slot AJ; Zuurmond AM; Bardoel AF; Wijmenga C; Pruijs HE; Sillence DO; Brinckmann J; Abraham DJ; Black CM; Verzijl N; DeGroot J; Hanemaaijer R; TeKoppele JM; Huizinga TW; Bank RA
J Biol Chem; 2003 Oct; 278(42):40967-72. PubMed ID: 12881513
[TBL] [Abstract][Full Text] [Related]
16. Genetic Analysis and Functional Study of a Pedigree With Bruck Syndrome Caused by
Wang RL; Ruan DD; Hu YN; Gan YM; Lin XF; Fang ZT; Liao LS; Tang FQ; He WB; Luo JW
Front Pediatr; 2022; 10():878172. PubMed ID: 35601416
[TBL] [Abstract][Full Text] [Related]
17. The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine.
Eyre D; Shao P; Weis MA; Steinmann B
Mol Genet Metab; 2002 Jul; 76(3):211-6. PubMed ID: 12126935
[TBL] [Abstract][Full Text] [Related]
18. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17.
Bank RA; Robins SP; Wijmenga C; Breslau-Siderius LJ; Bardoel AF; van der Sluijs HA; Pruijs HE; TeKoppele JM
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1054-8. PubMed ID: 9927692
[TBL] [Abstract][Full Text] [Related]
19. Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta.
Eyre DR; Weis MA
Calcif Tissue Int; 2013 Oct; 93(4):338-47. PubMed ID: 23508630
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro.
Uzawa K; Grzesik WJ; Nishiura T; Kuznetsov SA; Robey PG; Brenner DA; Yamauchi M
J Bone Miner Res; 1999 Aug; 14(8):1272-80. PubMed ID: 10457259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
